These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19059877)

  • 1. Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.
    Das R; Chen X; Komorowski R; Hessner MJ; Drobyski WR
    Blood; 2009 Mar; 113(10):2352-62. PubMed ID: 19059877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.
    Koyama M; Hill GR
    Blood; 2019 Dec; 134(24):2139-2148. PubMed ID: 31697827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
    Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
    Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.
    Foley JE; Mariotti J; Ryan K; Eckhaus M; Fowler DH
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):959-972. PubMed ID: 18721759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
    Hill GR; Teshima T; Gerbitz A; Pan L; Cooke KR; Brinson YS; Crawford JM; Ferrara JL
    J Clin Invest; 1999 Aug; 104(4):459-67. PubMed ID: 10449438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
    Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
    Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.
    Divito SJ; Aasebø AT; Matos TR; Hsieh PC; Collin M; Elco CP; O'Malley JT; Bækkevold ES; Reims H; Gedde-Dahl T; Hagerstrom M; Hilaire J; Lian JW; Milford EL; Pinkus GS; Ho VT; Soiffer RJ; Kim HT; Mihm MC; Ritz J; Guleria I; Cutler CS; Clark RA; Jahnsen FL; Kupper TS
    J Clin Invest; 2020 Sep; 130(9):4624-4636. PubMed ID: 32516138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.
    Hanash AM; Dudakov JA; Hua G; O'Connor MH; Young LF; Singer NV; West ML; Jenq RR; Holland AM; Kappel LW; Ghosh A; Tsai JJ; Rao UK; Yim NL; Smith OM; Velardi E; Hawryluk EB; Murphy GF; Liu C; Fouser LA; Kolesnick R; Blazar BR; van den Brink MR
    Immunity; 2012 Aug; 37(2):339-50. PubMed ID: 22921121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
    J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
    Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.
    Li H; Matte-Martone C; Tan HS; Venkatesan S; McNiff J; Demetris AJ; Jain D; Lakkis F; Rothstein D; Shlomchik WD
    J Immunol; 2011 Jan; 186(1):230-41. PubMed ID: 21098219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury.
    Panoskaltsis-Mortari A; Taylor PA; Rubin JS; Uren A; Welniak LA; Murphy WJ; Farrell CL; Lacey DL; Blazar BR
    Blood; 2000 Dec; 96(13):4350-6. PubMed ID: 11110712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease.
    Gendelman M; Hecht T; Logan B; Vodanovic-Jankovic S; Komorowski R; Drobyski WR
    J Immunol; 2004 Mar; 172(5):3328-36. PubMed ID: 14978141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.
    Gorczynski RM; Chen Z; Zeng H; Gorczynski L; Terzioglu E
    Immunology; 1998 Feb; 93(2):221-9. PubMed ID: 9616372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.
    Miura Y; Thoburn CJ; Bright EC; Chen W; Nakao S; Hess AD
    Blood; 2002 Oct; 100(7):2650-8. PubMed ID: 12239181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.
    Yang YG; Dey BR; Sergio JJ; Pearson DA; Sykes M
    J Clin Invest; 1998 Dec; 102(12):2126-35. PubMed ID: 9854048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and cytokine effectors of acute graft versus host disease.
    Ferrara JL
    Int J Hematol; 2002 Aug; 76 Suppl 1():195-8. PubMed ID: 12430853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
    Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
    Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.
    Wang MG; Szebeni J; Pearson DA; Szot GL; Sykes M
    Transplantation; 1995 Sep; 60(5):481-90. PubMed ID: 7676498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
    Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
    Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.